Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACP1 | P24666 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 2/20 | 0.43 |
| ▸ | ACP3 | P15309 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | MTOR | P42345 | 2/20 | 0.39 |
| ▸ | DAO | P14920 | 2/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11860963 | 0.87 | ACP1 (0.52) | ACP1IDO1CES2ACP3CA1 | |
| SCHEMBL7127796 | 0.83 | IDO1 (0.47) | ACP1IDO1CES2RXRARXRB | |
| SCHEMBL497366 | 0.82 | ACP3 (0.57) | IDO1CES2ACP3CA1CA2 | |
| SCHEMBL10478635 | 0.81 | ACP3 (0.56) | IDO1CES2ACP3CA1CA2 | |
| SCHEMBL2376293 | 0.79 | IDO1 (0.44) | ACP1IDO1CES2RXRARXRB | |
| SCHEMBL2376297 | 0.79 | IDO1 (0.44) | ACP1IDO1CES2RXRARXRB | |
| SCHEMBL4863519 | 0.79 | KIF11 (0.59) | ACP1IDO1CES2CA1CA2 | |
| SCHEMBL496716 | 0.79 | KIF11 (0.59) | IDO1CES2CA1CA2KIF11 | |
| SCHEMBL773148 | 0.79 | IDO1 (0.44) | ACP1IDO1CES2RXRARXRB | |
| Hydrochloric Acid SCHEMBL28126261 | 0.78 | KIF11 (0.58) | IDO1CES2KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | claimed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | claimed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | claimed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | claimed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| EP-2578577-A1 | Sulfonyl esters of tetrahydrocannabinol and derivatives thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2578561-A1 | Processes for the production of cannabidiol derivatives and intermediates thereof | Albany Molecular Research, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| US-8106244-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2012-01-31 | — | — | US | disclosed |
| US-20110263878-A1 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | ALBANY MOLECULAR RESEARCH, INC. (US) | 2011-10-27 | — | — | US | disclosed |
| US-20100069651-A1 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-18 | — | — | US | disclosed |
| US-7674922-B2 | Process for production of delta-9-tetrahydrocannabinol | ALBANY MOLECULAR RESEARCH, INC. (US) | 2010-03-09 | — | — | US | disclosed |
| EP-1928853-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR Technology, Inc. (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | AMR TECHNOLOGY, INC. (US) | 2007-04-26 | — | — | US | disclosed |
| WO-2007041167-A2 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | AMR TECHNOLOGY, INC. (US) | 2007-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069651-A1 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | CNR2, CNR1, HRH4 | ACP1 4698/4885IDO1 2033/4885CES2 688/4885 |
| US-20070093665-A1 | Process for production of delta-9- tetrahydrocannabinol | CNR2, CNR1, HRH4 | ACP1 4698/4885IDO1 2033/4885CES2 688/4885 |
| US-20110263878-A1 | PROCESS FOR PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL | CNR2, CNR1, HRH4 | ACP1 4698/4885IDO1 2033/4885CES2 688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.